E-Leviate Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 5

E-Leviate General Information

Description

Developer of a novel drug-device designed for women's health. The company provides structural and therapeutic support as a single integrated platform for a range of common gynecological conditions that affect most women during their lifetime and addresses conditions like vaginal atrophy, GSM, pelvic organ prolapse, urinary stress incontinence, and cystitis, enabling female non-surgical treatment with precision and care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 211 Ponsonby Road
  • Ponsonby
  • Auckland, 1011
  • New Zealand
+64 09
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Drug Discovery
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 211 Ponsonby Road
  • Ponsonby
  • Auckland, 1011
  • New Zealand
+64 09

E-Leviate Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

E-Leviate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Dec-2025 Completed Clinical Trials - General
1. Seed Round 01-Oct-2024 Completed Clinical Trials - General
To view E-Leviate’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

E-Leviate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

E-Leviate Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Soul Capital Impact Investing Minority
Clare Ventures Venture Capital Minority
Icehouse Ventures Venture Capital Minority
Nuance Connected Capital Venture Capital Minority
Outset Ventures Venture Capital Minority
To view E-Leviate’s complete investors history, request access »

E-Leviate FAQs

  • When was E-Leviate founded?

    E-Leviate was founded in 2023.

  • Where is E-Leviate headquartered?

    E-Leviate is headquartered in Auckland, New Zealand.

  • What is the size of E-Leviate?

    E-Leviate has 5 total employees.

  • What industry is E-Leviate in?

    E-Leviate’s primary industry is Therapeutic Devices.

  • Is E-Leviate a private or public company?

    E-Leviate is a Private company.

  • What is E-Leviate’s current revenue?

    The current revenue for E-Leviate is .

  • How much funding has E-Leviate raised over time?

    E-Leviate has raised $500K.

  • Who are E-Leviate’s investors?

    Soul Capital, Clare Ventures, Icehouse Ventures, Nuance Connected Capital, and Outset Ventures have invested in E-Leviate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process